Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 virusesQIAOLI LI; ZHENHUAN ZHAO; YINGLIANG WU et al.Peptides (New York, NY. 1980). 2011, Vol 32, Num 7, pp 1518-1525, issn 0196-9781, 8 p.Article

Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoVAIZHI ZHAO; WEIJUN QIN; YINGLU GUO et al.Microbes and infection. 2007, Vol 9, Num 8, pp 1026-1033, issn 1286-4579, 8 p.Article

Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4⁺ and CD8⁺ T cells promote cellular immune responsesJUN HUANG; YINGNAN CAO; JIALI DU et al.Vaccine. 2007, Vol 25, Num 39-40, pp 6981-6991, issn 0264-410X, 11 p.Article

SARS-CoV ORF1b-encoded nonstructural proteins 12-16: Replicative enzymes as antiviral targetsSUBISSI, Lorenzo; IMBERT, Isabelle; FERRON, François et al.Antiviral research. 2014, Vol 101, pp 122-130, issn 0166-3542, 9 p.Article

Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13YU, Mi-Sun; LEE, June; JIN MOO LEE et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 12, pp 4049-4054, issn 0960-894X, 6 p.Article

A complexity-based measure and its application to phylogenetic analysisXIAOQI ZHENG; CHUN LI; JUN WANG et al.Journal of mathematical chemistry. 2009, Vol 46, Num 4, pp 1149-1157, issn 0259-9791, 9 p.Article

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndromeLEE, Nelson; CHAN, P. K. S; IP, Margaret et al.Journal of clinical virology. 2006, Vol 35, Num 2, pp 179-184, issn 1386-6532, 6 p.Article

Development of antiviral therapy for severe acute respiratory syndromeCINATL, Jindrich JR; MICHAELIS, Martin; HOEVER, Gerold et al.Antiviral research. 2005, Vol 66, Num 2-3, pp 81-97, issn 0166-3542, 17 p.Article

The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replicationTYLOR, Shaun; ANDONOV, Anton; CUTTS, Todd et al.Canadian journal of microbiology. 2009, Vol 55, Num 3, pp 254-260, issn 0008-4166, 7 p.Article

Thrombopoietin levels increased in patients with severe acute respiratory syndromeMO YANG; NG, Margaret H. L; CHI KONG LI et al.Thrombosis research. 2008, Vol 122, Num 4, pp 473-477, issn 0049-3848, 5 p.Article

Study on the resistance of severe acute respiratory syndrome-associated coronavirusWANG, Xin-Wei; LI, Jin-Song; SI, Bing-Yin et al.Journal of virological methods. 2005, Vol 126, Num 1-2, pp 171-177, issn 0166-0934, 7 p.Article

A universal microarray for detection of SARS coronavirusLONG, Wei-Hong; XIAO, Hua-Sheng; GU, Xiao-Mei et al.Journal of virological methods. 2004, Vol 121, Num 1, pp 57-63, issn 0166-0934, 7 p.Article

Synthesis of Bioactive Natural Products as Protein InhibitorsKONNO, Hiroyuki.Bioscience, biotechnology, and biochemistry. 2012, Vol 76, Num 7, pp 1257-1261, issn 0916-8451, 5 p.Article

Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replicationAHN, Dae-Gyun; LEE, Wooseong; CHOI, Jin-Kyu et al.Antiviral research. 2011, Vol 91, Num 1, pp 1-10, issn 0166-3542, 10 p.Article

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidatesLIU, Shih-Jen; LENG, Chih-Hsiang; LIEN, Shu-Pei et al.Vaccine. 2006, Vol 24, Num 16, pp 3100-3108, issn 0264-410X, 9 p.Article

A serological survey on neutralizing antibody titer of SARS convalescent seraZHANG, Jian-San; CHEN, Jiang-Ting; XU, Jian-Guo et al.Journal of medical virology. 2005, Vol 77, Num 2, pp 147-150, issn 0146-6615, 4 p.Article

Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse modelHUI HU; XIANQING HUANG; LING TAO et al.Vaccine. 2009, Vol 27, Num 11, pp 1758-1763, issn 0264-410X, 6 p.Article

Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in miceHUI HU; LING TAO; YABIN WANG et al.Biotechnology letters. 2009, Vol 31, Num 11, pp 1685-1693, issn 0141-5492, 9 p.Article

Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic geneDAS, Dipankar; SURESH, Mavanur R.Journal of virological methods. 2006, Vol 137, Num 2, pp 343-346, issn 0166-0934, 4 p.Article

Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cellsMIZUTANI, Tetsuya; FUKUSHI, Shuetsu; LIZUKA, Daisuke et al.FEMS immunology and medical microbiology. 2006, Vol 46, Num 2, pp 236-243, issn 0928-8244, 8 p.Article

Obstacles and advances in SARS vaccine developmentTAYLOR, Deborah R.Vaccine. 2006, Vol 24, Num 7, pp 863-871, issn 0264-410X, 9 p.Article

A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptorCHOU, Chih-Fong; SHUO SHEN; TAN, Yee-Joo et al.Journal of virological methods. 2005, Vol 123, Num 1, pp 41-48, issn 0166-0934, 8 p.Article

Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirusIVENS, Tania; VAN DEN EYNDE, Christel; VAN ACKER, Koen et al.Journal of virological methods. 2005, Vol 129, Num 1, pp 56-63, issn 0166-0934, 8 p.Article

SARS-Coronavirus ancestor's foot-prints in South-East Asian bat colonies and the refuge theoryAR GOUILH, Meriadeg; PUECHMAILLE, Sebastien J; GONZALEZ, Jean-Paul et al.Infection, genetics and evolution (Print). 2011, Vol 11, Num 7, pp 1690-1702, issn 1567-1348, 13 p.Article

A rapid point of care immunoswab assay for SARS-CoV detectionKAMMILA, Sriram; DAS, Dipankar; BHATNAGAR, Pravin K et al.Journal of virological methods. 2008, Vol 152, Num 1-2, pp 77-84, issn 0166-0934, 8 p.Article